Texas Cardiac Arrhythmia Institute hosts EPLive 2026
Analysis based on 12 articles · First reported May 22, 2026 · Last updated May 22, 2026
The EPLive 2026 conference, hosted by the Texas Cardiac Arrhythmia Institute, showcases advancements in cardiac arrhythmia treatments, which could positively impact medical device companies involved in electrophysiology. Improved patient outcomes from streamlined procedures may also lead to broader adoption of new technologies, benefiting the healthcare sector.
The Texas Cardiac Arrhythmia Institute at St. David s Medical Center is hosting EPLive 2026, its eighth international symposium on complex cardiac arrhythmias, from May 28-29, 2026. The two-day conference will feature live and recorded cases from the Texas Cardiac Arrhythmia Institute and other premier electrophysiology centers globally, including those in Belgium, Canada, Colombia, Italy, and the United States. Andrea Natale, executive medical director of the Texas Cardiac Arrhythmia Institute, is the course director. The symposium will focus on a streamlined approach combining atrial fibrillation (A Fib) ablation and left atrial appendage occlusion (LAAO) into a single procedure to reduce stroke risk and complications. Physicians attending will receive American Medical Association Physician's Recognition Award Category 1 Credit hours.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard